... is to demonstrate the clinical utility of our programs, solidify our position at the forefront of cancer stem cell research and deliver new drugs for patients with cancer worldwide." Mr. Paterson has served as the Company's Chief Business Officer ...
http://ift.tt/1zAJ9Gz
http://ift.tt/1zAJ9Gz
No comments:
Post a Comment